HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate Total plaque, gingivitis claims evolution seen in FDA review documents.

This article was originally published in The Rose Sheet

Executive Summary

COLGATE TOTAL CLAIMS EVOLUTION SEEN IN FDA REVIEW DOCUMENTS recently made available by the agency for the .3% triclosan/.24% sodium fluoride OTC toothpaste. Colgate Total was approved July 11, 1997 as the first OTC dentifrice allowed to claim efficacy in the prevention of gingivitis, in addition to plaque, tartar, cavities and bad breath ("The Rose Sheet" July 21, 1997, p. 4). The company submitted NDA 20-231 to the agency Dec. 29, 1992; it was reviewed by FDA's Division of Dermatologic and Dental Drug Products.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005235

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel